Investors

Event Calendar

 

Upcoming Events

Year End 2022 Financial Results week of 06 March 2023

Read more


    Past Events

    ObsEva to Present at the H.C. Wainwright BioConnect 2022 Conference

    January 13, 2022

    Read more

    ObsEva Conference Call and Webcast 6th January

    January 6, 2022

    Read more

    ObsEva Announces Symposium and Presentation of Clinical Data on Oral GnRH Antagonist Linzagolix at SEUD Congress 2021

    December 10, 2021

    Read more
    1 2 3 4 5 31

    General Meetings

    ObsEva Annual General Meeting 2022

    May 18, 2022

    Read more

    ObsEva Annual General Meeting 2021

    May 28, 2021

    Read more
    1 2 3 4
     
     

    Sign up for news

     
     

      * Type:


      InvestorHCPNursePayerHospital PharmacistRetail PharmacistOther












      Read our privacy policy here.


       

      Are you sure you want to leave ObsEva.com?

      We’re sorry to see you go. Choose one of the following actions to stay on the site or leave.

      Continue to link

      Disclaimer

      Note that the following information contains information on investigational medicinal products. These products have not yet been approved for marketing by the European Medicines Agency or the U.S. Food and Drug Administration and are still under development. Further additional investigations may be needed in order for the marketing authorization to be granted, which grant may depend on a variety of factors and is not guaranteed. Click on “return” if you do not wish to receive such information. By clicking on “continue” you acknowledge that you wish to receive scientific information on our investigational products.

      Continue

      Disclaimer

      Note that the following information contains information on investigational medicinal products. These products have not yet been approved for marketing by the European Medicines Agency or the U.S. Food and Drug Administration and are still under development. Further additional investigations may be needed in order for the marketing authorization to be granted, which grant may depend on a variety of factors and is not guaranteed. Click on “return” if you do not wish to receive such information. By clicking on “continue” you acknowledge that you wish to receive scientific information on our investigational products.

      Continue